FenoMark develops and commercializes tools that enables next generation molecular testing.
FenoMark Diagnostics AB has raised $1.5M in total funding. The most recent round was Seed. The last funding was announced in December 2025.
FenoMark Diagnostics AB is headquartered in Stockholm, Sweden.
FenoMark develops and commercializes tools that enables next generation molecular testing.
FenoMark Diagnostics AB is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"FenoMark Diagnostics AB — Funding & Investors." VCBacked, December 16, 2025, https://www.vcbacked.co/company/fenomark-diagnostics-ab. Accessed August 17, 2026.
VCBacked. (2025). FenoMark Diagnostics AB — Funding & Investors. Retrieved August 17, 2026, from https://www.vcbacked.co/company/fenomark-diagnostics-ab
{{cite web |title=FenoMark Diagnostics AB — Funding & Investors |url=https://www.vcbacked.co/company/fenomark-diagnostics-ab |website=VCBacked |access-date=August 17, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated